A Double-blind and Randomized Trial of Celecoxib Added to Risperidone in Treatment-naive First-episode Schizophrenia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
A double-blind, randomized, placebo-controlled trial of celecoxib as an add-on therapy to risperidone compared to risperidone plus placebo in the treatment of 200 treatment-naive first-episode patients with schizophrenia. The study addresses an immune dysfunction hypothesis of schizophrenia.
Epistemonikos ID: 5ba9c0f8bda6617a0440e28b600d3f339d1b0758
First added on: May 05, 2024